Tuesday, June 1, 2021

THEMISMED | Potential Outperformer

 




Themis Medicare Limited

CMP  626


➽  Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, such as anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management.


➽ Key Stat

Financial Data Highlights

Market Cap734.78
Book Value/ Share237.699
Enterprise Value136.30
Revenue TTM230.67
Gross Profit TTM152.09
Revenue /Share TTM251.07

L&TFH | Stock Analysis And Price Outlook



Key Profit & Loss Data

Period31_Mar_2021Growth
Net Inc35.7044.07 %
Ops Income40.9529.59 %
Revenue230.6714.43 %
Ops Expense189.728.95 %
PBT41.3353.81 %
Gross Profit152.0918.20 %

DIXON | Stock Analysis And Price Outlook


 Price Outlook


Stock is in strong uptrend making higher high and higher low. In today's session it broke important neckline and is further ready for a sharp upside momentum.
Long for the levels of 783 in short term and 988 in the mid term.





Thanks for your Precious Time.


Finvest Online
Telegram  :  https://t.me/finvestonlineChat






Disclaime
r- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader,user and company that are mention on this website.We are not SEBI registered financial advisor or analyst.

No comments:

Post a Comment